Francesca Scassellati Sforzolini

Apr 11, 2024 | brunswickgroup.com | Ben Hirschler |Francesca Scassellati Sforzolini

Europe is updating its rules for how it regulates the pharmaceutical and life sciences industry – with far-reaching implications for its life sciences ecosystem. With the fine print to be negotiated over the coming months, companies still have time to make the case for innovation and ensure Europe doesn’t miss out on a once-in-a-generation opportunity. Are you ready for Europe’s new pharma rules? In the run-up to elections in June, Europe is getting ready to finalise new rules for pharmaceuticals.

Feb 5, 2024 | brunswickgroup.com | Francesca Scassellati Sforzolini |Ayesha Bharmal |Ben Hirschler

An interview with Richard Torbett, Chief Executive of the Association of the British Pharmaceutical Industry (ABPI). The UK government wants to make the country a life sciences ‘superpower’ by building on its academic strengths and deep pharmaceutical heritage. But in recent years, this enthusiasm has been at odds with a worsening operating environment that has made the UK a particularly tough market to navigate.